hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy

Title
hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 70, Issue 20, Pages 8077-8087
Publisher
American Association for Cancer Research (AACR)
Online
2010-10-07
DOI
10.1158/0008-5472.can-10-1313

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started